The DOI matches its Crossref record; 352 of the 352 references it cites were found in a registry or an index.
Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive review
Abstract
ABSTRACT Low drug bioavailability, which is mostly a result of poor aqueous drug solubilities and of inadequate drug dissolution rates, is one of the most significant challenges that pharmaceutical companies are currently facing, since this may limit the therapeutic efficacy of marketed drugs, or even result in the discard of potential highly effective drug candidates during developmental stages. Two of the main approaches that have been implemented in recent years to overcome poor drug solubility/dissolution issues have frequently involved drug particle size reduction (i.e., micronization/nanonization) and/or the modification of some of the physicochemical and structural properties of poorly water soluble drugs. A large number of particle engineering methodologies have been developed, tested, and applied in the synthesis and control of particle size/particle‐size distributions, crystallinities, and polymorphic purities of drug micro‐ and nano‐particles/crystals. In recent years pharmaceutical processing using supercritical fluids (SCF), in general, and supercritical carbon dioxide (scCO2), in particular, have attracted a great attention from the pharmaceutical industry. This is mostly due to the several well‐known advantageous technical features of these processes, as well as to other increasingly important subjects for the pharmaceutical industry, namely their “green”, sustainable, safe and “environmentally‐friendly” intrinsic characteristics. In this work, it is presented a comprehensive state‐of‐the‐art review on scCO2‐based processes focused on the formation and on the control of the physicochemical, structural and morphological properties of amorphous/crystalline pure drug nanoparticles. It is presented and discussed the most relevant scCO2, scCO2‐based fluids and drug physicochemical properties that are pertinent for the development of successful pharmaceutical products, namely those that are critical in the selection of an adequate scCO2‐based method to produce pure drug nanoparticles/nanocrystals. scCO2‐based nanoparticle formation methodologies are classified in three main families, and in terms of the most important role played by scCO2 in particle formation processes: as a solvent; as an antisolvent or a co‐antisolvent; and as a “high mobility” additive (a solute, a co‐solute, or a co‐solvent). Specific particle formation methods belonging to each one of these families are presented, discussed and compared. Some selected amorphous/crystalline drug nanoparticles that were prepared by these methods are compiled and presented, namely those studied in the last 10–15 years. A special emphasis is given to the formation of drug cocrystals. It is also discussed the fundamental knowledge and the main mechanisms in which the scCO2‐based particle formation methods rely on, as well as the current status and urgent needs in terms of reliable experimental data and of robust modeling approaches. Other addressed and discussed topics include the currently available and the most adequate physicochemical, morphological and biological characterization methods required for pure drug nanoparticles/nanocrystals, some of the current nanometrology and regulatory issues associated to the use of these methods, as well as some scale‐up, post‐processing and pharmaceutical regulatory subjects related to the industrial implementation of these scCO2‐based processes. Finally, it is also discussed the current status of these techniques, as well as their future major perspectives and opportunities for industrial implementation in the upcoming years. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Properties of Gases and Liquids
Reid, R. C., Sherwood, T. K., & Street, R. E. (1959) · Physics Today · doi:10.1063/1.3060771 · Cited by 14,143
The properties of gases and liquids
(2001) · Choice Reviews Online · doi:10.5860/choice.38-5036 · Cited by 12,958
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Green Chemistry: Principles and Practice
Anastas, P., & Eghbali, N. (2010) · Chem. Soc. Rev. · doi:10.1039/b918763b · Cited by 5,256
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
A method for estimating both the solubility parameters and molar volumes of liquids
Fedors, R. F. (1974) · Polymer Engineering & Science · doi:10.1002/pen.760140211 · Cited by 1,779
Pharmaceutical Particle Engineering via Spray Drying
Vehring, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,691
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460
Cited by
Nanoscale Drug Delivery Systems: From Medicine to Agriculture
Vega-Vásquez, P., Mosier, N. S., & Irudayaraj, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00079 · Cited by 323
Aerogels in drug delivery: From design to application
García-González, C. A., Sosnik, A., Kalmár, J., De Marco, I., Erkey, C., Concheiro, A., & Alvarez-Lorenzo, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.012 · Cited by 305
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Metadata
- Authors
- Padrela, L., Rodrigues, M. A., Duarte, A., Dias, A. M. A., Braga, M. E. M., & de Sousa, H. C.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 131
- Pages
- 22-78
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2883481262
- Cited by
- 262
- References
- 352
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive review. https://app.cochat.ai/papers/10.1016/j.addr.2018.07.010
- The paper
- Padrela, L., Rodrigues, M. A., Duarte, A., Dias, A. M. A., Braga, M. E. M., & de Sousa, H. C. (2018). Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive review. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2018.07.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.